Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $153 at Truist Securities

May 2, 2023 4:18 PM
Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $137.00) while maintaining a Hold rating.

Categories

Analyst PT Change

Next Articles